Bailey Timothy S, Wallace Jane F, Pardo Scott, Warchal-Windham Mary Ellen, Harrison Bern, Morin Robert, Christiansen Mark
1 AMCR Institute Inc., Escondido, CA, USA.
2 Ascensia Diabetes Care, Parsippany, NJ, USA.
J Diabetes Sci Technol. 2017 Jul;11(4):736-743. doi: 10.1177/1932296816680829. Epub 2017 Feb 1.
The new ContourPlus ONE blood glucose monitoring system (BGMS) features an easy-to-use, wireless-enabled blood glucose meter that links to a smart mobile device via Bluetooth connectivity and can sync with the Contour Diabetes app on a smartphone or tablet.
The accuracy of the new BGMS was assessed in 2 studies according to ISO 15197:2013 criteria. In Study 1 (laboratory study), fingertip capillary blood samples from 100 subjects were tested in duplicate using 3 test strip lots. In Study 2 (clinical study), 134 subjects with type 1 or type 2 diabetes enrolled at 2 clinical sites. BGMS results and YSI analyzer (YSI) reference results were compared for fingertip blood obtained by untrained subjects' self-testing and for study staff-obtained fingertip, subject palm, and venous results.
In Study 1, 99.0% (594/600) of combined results for all 3 test strip lots fulfilled ISO 15197:2013 Section 6.3 accuracy criteria. In Study 2, 99.2% (133/134) of subject-obtained capillary fingertip results, 99.2% (133/134) of study staff-obtained fingertip results, 99.2% (125/126) of subject-obtained palm results, and 100% (132/132) of study staff-obtained venous results met ISO 15197:2013 Section 8 accuracy criteria. Moreover, 95.5% (128/134) of subject-obtained fingertip self-test results were within ±10 mg/dl (±0.6 mmol/L) or ±10% of the YSI reference result. Questionnaire results showed that most subjects found the BGMS easy to use.
The BGMS exceeded ISO 15197:2013 accuracy criteria both in the laboratory and in a clinical setting when used by untrained subjects with diabetes.
新型ContourPlus ONE血糖监测系统(BGMS)的特点是拥有一款易于使用的、具备无线功能的血糖仪,该血糖仪通过蓝牙连接与智能移动设备相连,并且能够与智能手机或平板电脑上的Contour Diabetes应用程序同步。
根据ISO 15197:2013标准,在两项研究中评估了新型BGMS的准确性。在研究1(实验室研究)中,使用3批测试条对100名受试者的指尖毛细血管血样进行了重复检测。在研究2(临床研究)中,在2个临床地点招募了134名1型或2型糖尿病患者。比较了未经培训的受试者自测获得的指尖血、研究人员获得的指尖血、受试者手掌血和静脉血的BGMS结果与YSI分析仪(YSI)参考结果。
在研究1中,所有3批测试条的综合结果中有99.0%(594/600)符合ISO 15197:2013第6.3节的准确性标准。在研究2中,受试者获得的毛细血管指尖结果中有99.2%(133/134)、研究人员获得的指尖结果中有99.2%(133/134)、受试者获得的手掌结果中有99.2%(125/126)以及研究人员获得的静脉结果中有100%(132/132)符合ISO 15197:2013第8节的准确性标准。此外,受试者获得的指尖自测结果中有95.5%(128/134)在YSI参考结果的±10 mg/dl(±0.6 mmol/L)或±10%范围内。问卷调查结果显示,大多数受试者认为BGMS易于使用。
当糖尿病患者未经培训使用时,BGMS在实验室和临床环境中均超过了ISO 15197:2013的准确性标准。